Cargando…

Current role of neuromodulation in bladder pain syndrome/interstitial cystitis

Neuromodulation is recommended by major international guidelines as a fourth-line treatment in bladder pain syndrome/interstitial cystitis (BPS/IC) patients after failure of behavioural, oral and intravesical pharmacological treatments, including hydrodistension. A non-systematic review of studies i...

Descripción completa

Detalles Bibliográficos
Autores principales: Padilla-Fernández, Bárbara, Hernández-Hernández, David, Castro-Díaz, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685149/
https://www.ncbi.nlm.nih.gov/pubmed/36438605
http://dx.doi.org/10.1177/17562872221135941
_version_ 1784835439712010240
author Padilla-Fernández, Bárbara
Hernández-Hernández, David
Castro-Díaz, David M.
author_facet Padilla-Fernández, Bárbara
Hernández-Hernández, David
Castro-Díaz, David M.
author_sort Padilla-Fernández, Bárbara
collection PubMed
description Neuromodulation is recommended by major international guidelines as a fourth-line treatment in bladder pain syndrome/interstitial cystitis (BPS/IC) patients after failure of behavioural, oral and intravesical pharmacological treatments, including hydrodistension. A non-systematic review of studies identified by electronic search of MEDLINE was performed with no time limitation. A narrative synthesis of the existing evidence regarding the results of sacral, tibial and pudendal nerve stimulation in the management of BPS/IC was developed. Neuromodulation in pelvic chronic pain disorders, including BPS/IC, is a useful tool for refractory patients to conventional treatments. Sacral neuromodulation may be effective in patients with BPS without Hunner’s lesions, and the effect seems to be maintained in the mid- and long-term. Posterior tibial nerve stimulation can be offered to patients with BPS/IC in the context of a multidisciplinary approach. When pudendal neuralgia is suspected, selective pudendal nerve stimulation has a high response rate. The aetiology of the pain can influence the outcomes in the mid- and long-term of the different neuromodulation approaches, thus careful diagnosis is recommended.
format Online
Article
Text
id pubmed-9685149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-96851492022-11-25 Current role of neuromodulation in bladder pain syndrome/interstitial cystitis Padilla-Fernández, Bárbara Hernández-Hernández, David Castro-Díaz, David M. Ther Adv Urol Advances in Urogynaecology Neuromodulation is recommended by major international guidelines as a fourth-line treatment in bladder pain syndrome/interstitial cystitis (BPS/IC) patients after failure of behavioural, oral and intravesical pharmacological treatments, including hydrodistension. A non-systematic review of studies identified by electronic search of MEDLINE was performed with no time limitation. A narrative synthesis of the existing evidence regarding the results of sacral, tibial and pudendal nerve stimulation in the management of BPS/IC was developed. Neuromodulation in pelvic chronic pain disorders, including BPS/IC, is a useful tool for refractory patients to conventional treatments. Sacral neuromodulation may be effective in patients with BPS without Hunner’s lesions, and the effect seems to be maintained in the mid- and long-term. Posterior tibial nerve stimulation can be offered to patients with BPS/IC in the context of a multidisciplinary approach. When pudendal neuralgia is suspected, selective pudendal nerve stimulation has a high response rate. The aetiology of the pain can influence the outcomes in the mid- and long-term of the different neuromodulation approaches, thus careful diagnosis is recommended. SAGE Publications 2022-11-21 /pmc/articles/PMC9685149/ /pubmed/36438605 http://dx.doi.org/10.1177/17562872221135941 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Advances in Urogynaecology
Padilla-Fernández, Bárbara
Hernández-Hernández, David
Castro-Díaz, David M.
Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
title Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
title_full Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
title_fullStr Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
title_full_unstemmed Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
title_short Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
title_sort current role of neuromodulation in bladder pain syndrome/interstitial cystitis
topic Advances in Urogynaecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685149/
https://www.ncbi.nlm.nih.gov/pubmed/36438605
http://dx.doi.org/10.1177/17562872221135941
work_keys_str_mv AT padillafernandezbarbara currentroleofneuromodulationinbladderpainsyndromeinterstitialcystitis
AT hernandezhernandezdavid currentroleofneuromodulationinbladderpainsyndromeinterstitialcystitis
AT castrodiazdavidm currentroleofneuromodulationinbladderpainsyndromeinterstitialcystitis